Celestica Surges on Q3 Beat and Raised Guidance, but Key Thesis Questions Remain

What happened

Celestica shares jumped more than 16% in pre-market trading after the company reported better-than-expected fiscal third-quarter 2026 results and raised full-year guidance, signaling continued strong demand from hyperscaler AI infrastructure programs. The beat builds on the company's momentum from Q2, when revenue grew 62% and management raised revenue guidance to $19.0 billion, but the market's reaction suggests some of the prior skepticism about execution and capacity conversion has eased. However, the release alone does not confirm that the company's 1.6 terabit networking products have begun shipping at scale or that gross margin has stabilized above the 12.3% threshold needed to offset dilution from the August equity raise. The stock had been trading around $344 recently, and the 16% pre-market move lifts it toward or above the $390 'trim above' level identified in our WAIT thesis, raising the bar for new money. Investors should scrutinize the actual Q3 filings for inventory growth relative to revenue, customer deposit trends, and any commentary on 1.6T deployment before concluding that the thesis has fundamentally improved.

Implication

Investors should treat the sharp rally as a confirmation of revenue momentum rather than a signal to chase, given that the stock remains richly valued at roughly 35x earnings and the company's economic moat is still unproven beyond manufacturing leverage. The raised full-year guidance likely reflects continued strength in communications and enterprise segments, but the key question is whether that strength is translating into higher gross margin or simply more volume with flat economics. Our base case already assumed hyperscaler spending would remain strong, so the beat may not materially change the expected value; what matters is whether Q4 and early 2027 show 1.6T programs contributing revenue and gross margin exceeding 12.3%. If the company can demonstrate that the August equity raise is funding productive capacity and inventory is converting to revenue efficiently, the thesis would shift from WAIT to a potential BUY on pullbacks near $300. Conversely, if the beat is driven by pull-ins or one-time items and gross margin remains stagnant, the stock could be vulnerable to a sharp correction after the initial euphoria.

Thesis delta

The Q3 beat and raised guidance are incrementally positive and reduce the probability of the bear case where hyperscaler demand weakens, but they do not by themselves confirm that Celestica is converting its huge revenue growth into profitable per-share value. Our WAIT rating remains appropriate because the stock's valuation now leaves little room for execution error, and the key milestones we set—1.6T shipping at scale and gross margin above 12.3%—have not yet been verified in a filing. We will look for evidence in the upcoming 10-Q and analyst day commentary that inventory discipline and margin expansion accompany the revenue beat.